Evidence map›Paper›PMID 31730647›Full record

ArticlePLoS genetics2019

Gpr63 is a modifier of microcephaly in Ttc21b mouse mutants.

John Snedeker, William J Gibbons, David F Paulding, Zakia Abdelhamed, Daniel R Prows, Rolf W Stottmann

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Centriolar Protein C2cd3 Is Required for Craniofacial Development.Frontiers in cell and developmental biology · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

John SnedekerDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
William J GibbonsDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
David F PauldingDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.ORCID 0000-0002-7692-7924
Zakia AbdelhamedDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.
Daniel R ProwsDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.ORCID 0000-0003-0049-148X
Rolf W StottmannDivision of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America.ORCID 0000-0003-4512-6806
Cincinnati Children's Hospital Medical Center · US

Funding

Molecular Analysis of primary cilia proteins in human development and diseaseR35GM131875 · NIGMS · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI STOTTMANN, ROLF W · 2019 to 2023
$2.0M
A genetic approach to defining the Ttc21b interactome in mammalian ciliopathiesR01GM112744 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI STOTTMANN, ROLF W · 2015 to 2018
$1.2M
NIGMS NIH HHS R01 GM112744NIGMS NIH HHS R35 GM131875
6 · The paper itself

Abstract

The primary cilium is a signaling center critical for proper embryonic development. Previous studies have demonstrated that mice lacking Ttc21b have impaired retrograde trafficking within the cilium and multiple organogenesis phenotypes, including microcephaly. Interestingly, the severity of the microcephaly in Ttc21baln/aln homozygous null mutants is considerably affected by the genetic background and mutants on an FVB/NJ (FVB) background develop a forebrain significantly smaller than mutants on a C57BL/6J (B6) background. We performed a Quantitative Trait Locus (QTL) analysis to identify potential genetic modifiers and identified two regions linked to differential forebrain size: modifier of alien QTL1 (Moaq1) on chromosome 4 at 27.8 Mb and Moaq2 on chromosome 6 at 93.6 Mb. These QTLs were validated by constructing congenic strains. Further analysis of Moaq1 identified an orphan G-protein coupled receptor (GPCR), Gpr63, as a candidate gene. We identified a SNP that is polymorphic between the FVB and B6 strains in Gpr63 and creates a missense mutation predicted to be deleterious in the FVB protein. We used CRISPR-Cas9 genome editing to create two lines of FVB congenic mice: one with the B6 sequence of Gpr63 and the other with a deletion allele leading to a truncation of the GPR63 C-terminal tail. We then demonstrated that Gpr63 can localize to the cilium in vitro. These alleles affect ciliary localization of GPR63 in vitro and genetically interact with Ttc21baln/aln as Gpr63;Ttc21b double mutants show unique phenotypes including spina bifida aperta and earlier embryonic lethality. This validated Gpr63 as a modifier of multiple Ttc21b neural phenotypes and strongly supports Gpr63 as a causal gene (i.e., a quantitative trait gene, QTG) within the Moaq1 QTL.

Indexed as

Adaptor Proteins, Signal TransducingAllelesAnimalsChromosome MappingCiliaCRISPR-Cas SystemsEmbryo, MammalianEmbryonic DevelopmentGenotypeHumansMiceMice, Inbred C57BLMicrocephalyProsencephalonQuantitative Trait LociReceptors, G-Protein-CoupledAdaptor Proteins, Signal TransducingGPR63 protein, humanReceptors, G-Protein-CoupledTtc21b protein, mouse

Identifiers

PMID31730647
PMCPMC6881074
OpenAlexW2986453791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.